{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:13:32Z","timestamp":1769724812322,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA154848"],"award-info":[{"award-number":["R01CA154848"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA177558-05S3"],"award-info":[{"award-number":["P30CA177558-05S3"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2T32CA093423"],"award-info":[{"award-number":["2T32CA093423"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001432"],"award-info":[{"award-number":["KL2TR001432"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002649"],"award-info":[{"award-number":["UL1TR002649"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00520-019-05247-5","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:55:43Z","timestamp":1577969743000},"page":"4147-4154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-0278","authenticated-orcid":false,"given":"Arnethea L.","family":"Sutton","sequence":"first","affiliation":[]},{"given":"Teresa M.","family":"Salgado","sequence":"additional","affiliation":[]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[]},{"given":"Alejandra","family":"Hurtado-de-Mendoza","sequence":"additional","affiliation":[]},{"given":"Vanessa B.","family":"Sheppard","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"5247_CR1","unstructured":"American Cancer Society (2019) Breast Cancer Facts & Figures, in American Cancer Society I (ed). Atlanta."},{"issue":"14","key":"5247_CR2","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.ejca.2009.05.022","volume":"45","author":"S Alkner","year":"2009","unstructured":"Alkner S, Bendahl PO, Ferno M, Nordenskjold B, Ryden L, South S, South-East Swedish Breast Cancer G (2009) Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial. Eur J Cancer 45(14):2496\u20132502. https:\/\/doi.org\/10.1016\/j.ejca.2009.05.022","journal-title":"Eur J Cancer"},{"issue":"9793","key":"5247_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"C Davies","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative G, Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771\u2013784. https:\/\/doi.org\/10.1016\/S0140-6736(11)60993-8","journal-title":"Lancet"},{"issue":"1","key":"5247_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"JF Forbes","year":"2008","unstructured":"Arimidex TAoiCTG, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9(1):45\u201353","journal-title":"Lancet Oncol"},{"issue":"9472","key":"5247_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group E","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group E (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"3","key":"5247_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1055-9965.Epi-12-1225","volume":"22","author":"JC Livaudais","year":"2013","unstructured":"Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD (2013) Racial\/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women\u2019s health initiative. Cancer Epidemiol Biomark Prev 22(3):365\u2013373. https:\/\/doi.org\/10.1158\/1055-9965.Epi-12-1225","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"5247_CR7","doi-asserted-by":"publisher","first-page":"19-016-0732-073","DOI":"10.1007\/s12032-016-0732-1","volume":"33","author":"AJ Farias","year":"2016","unstructured":"Farias AJ, Du XL (2016) Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare part D. Med Oncol 33(2):19-016-0732-0731. https:\/\/doi.org\/10.1007\/s12032-016-0732-1","journal-title":"Med Oncol"},{"issue":"2","key":"5247_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","volume":"134","author":"CC Murphy","year":"2012","unstructured":"Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134(2):459\u2013478. https:\/\/doi.org\/10.1007\/s10549-012-2114-5","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"5247_CR9","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","volume":"28","author":"DL Hershman","year":"2010","unstructured":"Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Gomez SL, Miles S, Neugut AI (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120\u20134128. https:\/\/doi.org\/10.1200\/JCO.2009.25.9655","journal-title":"J Clin Oncol"},{"issue":"2","key":"5247_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s13187-017-1180-0","volume":"33","author":"A Hurtado-de-Mendoza","year":"2018","unstructured":"Hurtado-de-Mendoza A, Jensen RE, Jennings Y, Sheppard VB (2018) Understanding breast cancer survivors\u2019 beliefs and concerns about adjuvant hormonal therapy: promoting adherence. J Cancer Educ 33(2):436\u2013439. https:\/\/doi.org\/10.1007\/s13187-017-1180-0","journal-title":"J Cancer Educ"},{"issue":"4","key":"5247_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.sapharm.2016.08.004","volume":"13","author":"X Tan","year":"2017","unstructured":"Tan X, Camacho F, Marshall VD, Donohoe J, Anderson RT, Balkrishnan R (2017) Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer. Res Social Adm Pharm 13(4):796\u2013810. https:\/\/doi.org\/10.1016\/j.sapharm.2016.08.004","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"5247_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10549-016-3788-x","volume":"157","author":"DL Hershman","year":"2016","unstructured":"Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jacobson JS, Wright JD, Neugut AI (2016) Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat 157(1):133\u2013143. https:\/\/doi.org\/10.1007\/s10549-016-3788-x","journal-title":"Breast Cancer Res Treat"},{"key":"5247_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/PPA.S126651","volume":"11","author":"Z Moon","year":"2017","unstructured":"Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD (2017) Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence 11:305\u2013322. https:\/\/doi.org\/10.2147\/PPA.S126651","journal-title":"Patient Prefer Adherence"},{"key":"5247_CR14","doi-asserted-by":"publisher","unstructured":"Qvarnstrom M, Kahan T, Kieler H, Brandt L, Hasselstrom J, Wettermark B (2019) Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients. Blood Press 1\u20138. https:\/\/doi.org\/10.1080\/08037051.2019.1627858","DOI":"10.1080\/08037051.2019.1627858"},{"issue":"3","key":"5247_CR15","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.18295\/squmj.2017.17.03.012","volume":"17","author":"H Al-Noumani","year":"2017","unstructured":"Al-Noumani H, Wu JR, Barksdale D, Alkhasawneh E, Knafl G, Sherwood G (2017) Relationship between medication adherence and health beliefs among patients with hypertension in Oman: pilot study. Sultan Qaboos Univ Med J 17(3):e329\u2013e333. https:\/\/doi.org\/10.18295\/squmj.2017.17.03.012","journal-title":"Sultan Qaboos Univ Med J"},{"key":"5247_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-019-05145-8","volume":"175","author":"KC Kadakia","year":"2019","unstructured":"Kadakia KC, Kidwell KM, Barton DL, Schott AF, Hayes DF, Griggs JJ, Henry NL (2019) Factors influencing the use of extended adjuvant endocrine therapy. Breast Cancer Res Treat 175:181\u2013189. https:\/\/doi.org\/10.1007\/s10549-019-05145-8","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5247_CR17","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.clbc.2018.10.008","volume":"19","author":"RJ Thorneloe","year":"2019","unstructured":"Thorneloe RJ, Horne R, Side L, Wolf MS, Smith SG (2019) Beliefs about medication and uptake of preventive therapy in women at increased risk of breast cancer: results from a multicenter prospective study. Clin Breast Cancer 19(1):e116\u2013e126. https:\/\/doi.org\/10.1016\/j.clbc.2018.10.008","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"5247_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-016-3871-3","volume":"158","author":"EE Bright","year":"2016","unstructured":"Bright EE, Petrie KJ, Partridge AH, Stanton AL (2016) Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer. Breast Cancer Res Treat 158(2):243\u2013251. https:\/\/doi.org\/10.1007\/s10549-016-3871-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5247_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10549-014-2961-3","volume":"145","author":"AL Stanton","year":"2014","unstructured":"Stanton AL, Petrie KJ, Partridge AH (2014) Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat 145(2):525\u2013534. https:\/\/doi.org\/10.1007\/s10549-014-2961-3","journal-title":"Breast Cancer Res Treat"},{"key":"5247_CR20","doi-asserted-by":"publisher","unstructured":"Brett J, Fenlon D, Boulton M, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Watson E (2018) Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer. Eur J Cancer Care (Engl) 27(1). https:\/\/doi.org\/10.1111\/ecc.12601","DOI":"10.1111\/ecc.12601"},{"issue":"5","key":"5247_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/jco.18.01160","volume":"37","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ (2019) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 37(5):423\u2013438. https:\/\/doi.org\/10.1200\/jco.18.01160","journal-title":"J Clin Oncol"},{"issue":"2","key":"5247_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-017-4177-9","volume":"163","author":"TM Salgado","year":"2017","unstructured":"Salgado TM, Davis EJ, Farris KB, Fawaz S, Batra P, Henry NL (2017) Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer. Breast Cancer Res Treat 163(2):311\u2013319. https:\/\/doi.org\/10.1007\/s10549-017-4177-9","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"5247_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0961203311398512","volume":"20","author":"K Kumar","year":"2011","unstructured":"Kumar K, Gordon C, Barry R, Shaw K, Horne R, Raza K (2011) It\u2019s like taking poison to kill poison but I have to get better\u2019: a qualitative study of beliefs about medicines in rheumatoid arthritis and systemic lupus erythematosus patients of South Asian origin. Lupus 20(8):837\u2013844. https:\/\/doi.org\/10.1177\/0961203311398512","journal-title":"Lupus"},{"issue":"1","key":"5247_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11764-017-0646-8","volume":"12","author":"VB Sheppard","year":"2018","unstructured":"Sheppard VB, Hurtado-de-Mendoza A, Zheng YL, Wang Y, Graves KD, Lobo T, Xu H, Jennings Y, Tolsma D, Trout M, Robinson BE, McKinnon B, Tadesse M (2018) Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine. J Cancer Surviv 12(1):74\u201381. https:\/\/doi.org\/10.1007\/s11764-017-0646-8","journal-title":"J Cancer Surviv"},{"key":"5247_CR25","doi-asserted-by":"crossref","unstructured":"Pellegrini I, Sarradon-Eck A, Ben Soussan P, Lacour AC, Largillier R, Tallet A, Tarpin C, Julian-Reynier C (2010) Women\u2019s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients\u2019 point of view. Psychooncology 19(5): 472479.","DOI":"10.1002\/pon.1593"},{"issue":"2","key":"5247_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55(2):189\u2013199","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5247_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pec.2004.09.005","volume":"57","author":"MS Wolf","year":"2005","unstructured":"Wolf MS, Chang CH, Davis T, Makoul G (2005) Development and validation of the communication and attitudinal self-efficacy scale for cancer (CASE-cancer). Patient Educ Couns 57(3):333\u2013341","journal-title":"Patient Educ Couns"},{"issue":"3","key":"5247_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00003727-200110000-00008","volume":"24","author":"SN Lukwago","year":"2001","unstructured":"Lukwago SN, Kreuter MW, Bucholtz DC, Holt CL, Clark EM (2001) Development and validation of brief scales to measure collectivism, religiosity, racial pride, and time orientation in urban African American women. Fam Community Health 24(3):63\u201371","journal-title":"Fam Community Health"},{"issue":"3","key":"5247_CR29","first-page":"554","volume":"11","author":"ST Bird","year":"2001","unstructured":"Bird ST, Bogart LM (2001) Perceived race-based and socioeconomic status(SES)-based discrimination in interactions with health care providers. Ethn Dis 11(3):554\u2013563","journal-title":"Ethn Dis"},{"issue":"6","key":"5247_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32(6):705\u2013714","journal-title":"Soc Sci Med"},{"key":"5247_CR31","unstructured":"National comprehensive cancer network: NCCN clinical practice guidelines in oncology v. 2 (2008)"},{"key":"5247_CR32","unstructured":"Marshall G, Hays RD (1994) The patient satisfaction questionnaire short-form (PSQ-18), P-7865. Vol book, whole"},{"issue":"1","key":"5247_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0738-3991(03)00085-5","volume":"50","author":"G Makoul","year":"2003","unstructured":"Makoul G (2003) The interplay between education and research about patient-provider communication. Patient Educ Couns 50(1):79\u201384","journal-title":"Patient Educ Couns"},{"issue":"5","key":"5247_CR34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/00005650-199805000-00012","volume":"36","author":"DG Safran","year":"1998","unstructured":"Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE (1998) The primary care assessment survey: tests of data quality and measurement performance. Med Care 36(5):728\u2013739","journal-title":"Med Care"},{"issue":"6","key":"5247_CR35","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1475-6773.2009.01017.x","volume":"44","author":"TA LaVeist","year":"2009","unstructured":"LaVeist TA, Isaac LA, Williams KP (2009) Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res 44(6):2093\u20132105. https:\/\/doi.org\/10.1111\/j.1475-6773.2009.01017.x","journal-title":"Health Serv Res"},{"issue":"1","key":"5247_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00432-014-1779-z","volume":"141","author":"P Wuensch","year":"2015","unstructured":"Wuensch P, Hahne A, Haidinger R, Meissler K, Tenter B, Stoll C, Senf B, Huebner J (2015) Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor? J Cancer Res Clin Oncol 141(1):55\u201360. https:\/\/doi.org\/10.1007\/s00432-014-1779-z","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5247_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/hiv.12542","volume":"19","author":"S Kamal","year":"2018","unstructured":"Kamal S, Bugnon O, Cavassini M, Schneider MP (2018) HIV-infected patients\u2019 beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy. HIV Med 19(1):49\u201358. https:\/\/doi.org\/10.1111\/hiv.12542","journal-title":"HIV Med"},{"key":"5247_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/ppa.S145784","volume":"12","author":"J Brett","year":"2018","unstructured":"Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK (2018) Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence. Patient Prefer Adherence 12:291\u2013300. https:\/\/doi.org\/10.2147\/ppa.S145784","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"5247_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00520-016-3389-6","volume":"25","author":"AJ Farias","year":"2017","unstructured":"Farias AJ, Ornelas IJ, Hohl SD, Zeliadt SB, Hansen RN, Li CI, Thompson B (2017) Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Support Care Cancer 25(1):75\u201383. https:\/\/doi.org\/10.1007\/s00520-016-3389-6","journal-title":"Support Care Cancer"},{"issue":"5","key":"5247_CR40","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s10943-018-0606-2","volume":"57","author":"B Badanta-Romero","year":"2018","unstructured":"Badanta-Romero B, de Diego-Cordero R, Rivilla-Garcia E (2018) Influence of religious and spiritual elements on adherence to pharmacological treatment. J Relig Health 57(5):1905\u20131917. https:\/\/doi.org\/10.1007\/s10943-018-0606-2","journal-title":"J Relig Health"},{"issue":"8","key":"5247_CR41","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/09540121.2014.882486","volume":"26","author":"KJ Vyas","year":"2014","unstructured":"Vyas KJ, Limneos J, Qin H, Mathews WC (2014) Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons. AIDS Care 26(8):983\u2013987. https:\/\/doi.org\/10.1080\/09540121.2014.882486","journal-title":"AIDS Care"},{"key":"5247_CR42","unstructured":"National Collaborating Centre for Primary Care (UK) (2009) Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. Royal College of General Practitioners (UK), London."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05247-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:46:06Z","timestamp":1609461966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5247"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05247-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}